GlassScriptPhysician profile
Ryan Douglas Endress
NPI 1457549446
$79,736.53
in general payments reported to CMS, 2019-2025
35 companies · $3,683 in 2025
The $3,683 reported for 2025 was more than what 89% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $735 · 2020: $1,173 · 2021: $4,043 · 2022: $52K · 2023: $15K · 2024: $3,647 · 2025: $3,683.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Travel and Lodging: $4,755 · Food and Beverage: $4,274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,912.50 |
| Travel and Lodging | $4,754.66 |
| Food and Beverage | $4,274.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Valencia Technologies Corporation | $49,473.99 | 2022 | |
| Axogen | $18,227.65 | 2019-2024 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector |
| Access Pro Medical, LLC | $3,058.33 | 2022-2025 | Matriderm, Matriderm |
| In2bones USA, LLC | $2,309.75 | 2019-2022 | |
| Abbvie INC. | $2,001.89 | 2024-2025 | |
| Integra Lifesciences Corporation | $1,041.08 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Avita Medical Americas, LLC | $586.28 | 2021-2025 | Permeaderm, Cohealyx, Recell |
| Smith+Nephew, INC. | $400.11 | 2021-2025 | Oasis, Evos Mini, Collagenase Santyl |
| Kerecis Limited | $391.99 | 2021-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Musculoskeletal Transplant Foundation INC. | $291.67 | 2020-2023 | |
| Mentor Worldwide LLC | $253.35 | 2019-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Medtronic, INC. | $186.40 | 2021-2022 | |
| Polynovo North America LLC | $181.66 | 2020-2024 | Novosorb Btm |
| Stryker Corporation | $175.10 | 2019-2024 | Evolve Triad |
| Depuy Synthes Sales INC. | $147.04 | 2025 | Dynaforce, Fibergraft Aeridyan Matrix, Na |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $141.01 | 2023-2025 | Restrata Wound Matrix |
| Baxter Healthcare | $127.42 | 2019-2024 | |
| Aroa Biosurgery Incorporated | $111.64 | 2022 | |
| Sonex Health, INC. | $109.02 | 2024 | Sx-One Microknife |
| Motiva USA, LLC | $97.67 | 2025 | |
| Solta Medical, A Division of Bausch Health US, LLC | $61.32 | 2025 | |
| Checkpoint Surgical, INC | $55.45 | 2024 | Checkpoint Stimulators |
| Tela Bio, INC. | $44.18 | 2021 | |
| Kci USA, INC. | $28.96 | 2023 | V.A.C. Veraflo, Prevena |
| Edwards Lifesciences Corporation | $27.74 | 2021 | |
| Tepha INC | $26.04 | 2019 | |
| Dilon Technologies, INC. | $26.04 | 2025 | Hemoblast Bellows |
| Bioventus LLC | $24.33 | 2024 | Exogen Ultrasound Bone Healing System |
| Mimedx Group, INC. | $24.12 | 2024 | |
| Btg International INC. | $23.99 | 2025 | Aurlumyn |
| Endo USA, INC. | $19.69 | 2024 | Xiaflex |
| Endo Pharmaceuticals INC. | $18.90 | 2024 | Xiaflex |
| Innovation Technologies INC | $17.24 | 2022 | |
| Teleflex LLC | $13.53 | 2022 | |
| Wright Medical Technology, INC. | $11.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$125,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Endress listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.